CLINICAL ROLE -
Researchers Explore Oncolytic Polymers as the Key to Fighting Tumor Heterogenicity
Oncolytic polymers may be the answer to circumventing therapeutic resistance in cancer treatment.
Read More
Pharmacists Could Be Solution to Polypharmacy in Patients With Cancer
Up to 81% of patients with cancer take medications to treat their other comorbidities.
Pharmacists to Take the Reins of Leading Clinical Trials for Children’s Oncology Group
As the resident medication experts, pharmacists are qualified to answer any medication-related questions and conduct data analyses.
